Glassman Wealth Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,153
| Closed | -$644K | – | 210 |
|
|
2023
Q4 | $644K | Sell |
4,153
-46
| -1% | -$6.71K | 0.09% | 71 |
|
|
2023
Q3 | $626K | Buy |
4,199
+133
| +3% | +$19.5K | 0.1% | 66 |
|
|
2023
Q2 | $548K | Sell |
4,066
-701
| -15% | -$103K | 0.09% | 71 |
|
|
2023
Q1 | $760K | Buy |
4,767
+85
| +2% | +$13K | 0.13% | 50 |
|
|
2022
Q4 | $757K | Buy |
4,682
+591
| +14% | +$90.6K | 0.14% | 50 |
|
|
2022
Q3 | $549K | Buy |
4,091
+99
| +2% | +$14.2K | 0.12% | 64 |
|
|
2022
Q2 | $611K | Buy |
3,992
+94
| +2% | +$14.4K | 0.13% | 65 |
|
|
2022
Q1 | $632K | Buy |
3,898
+305
| +8% | +$44.3K | 0.12% | 70 |
|
|
2021
Q4 | $486K | Buy |
3,593
+376
| +12% | +$44.4K | 0.09% | 84 |
|
|
2021
Q3 | $347K | Buy |
3,217
+2,273
| +241% | +$260K | 0.07% | 99 |
|
|
2021
Q2 | $106K | Buy |
944
+107
| +13% | +$12.1K | 0.02% | 223 |
|
|
2021
Q1 | $91K | Sell |
837
-76
| -8% | -$8.13K | 0.02% | 232 |
|
|
2020
Q4 | $98K | Sell |
913
-5
| -0.5% | -$480 | 0.02% | 229 |
|
|
2020
Q3 | $80K | Buy |
918
+236
| +35% | +$22.2K | 0.02% | 226 |
|
|
2020
Q2 | $67K | Buy |
682
+92
| +16% | +$8.1K | 0.02% | 208 |
|
|
2020
Q1 | $45K | Sell |
590
-3
| -0.5% | -$256 | 0.02% | 240 |
|
|
2019
Q4 | $53K | Buy |
593
+111
| +23% | +$9.21K | 0.02% | 252 |
|
|
2019
Q3 | $36K | Sell |
482
-185
| -28% | -$12.7K | 0.01% | 278 |
|
|
2019
Q2 | $49K | Buy |
667
+132
| +25% | +$10.4K | 0.02% | 238 |
|
|
2019
Q1 | $43K | Buy |
535
+163
| +44% | +$13.3K | 0.02% | 246 |
|
|
2018
Q4 | $34K | Buy |
372
+10
| +3% | +$879 | 0.02% | 234 |
|
|
2018
Q3 | $34K | Sell |
362
-118
| -25% | -$11.2K | 0.02% | 251 |
|
|
2018
Q2 | $44K | Buy |
480
+9
| +2% | +$879 | 0.02% | 197 |
|
|
2018
Q1 | $45K | Buy |
471
+140
| +42% | +$15.4K | 0.03% | 186 |
|
|
2017
Q4 | $32K | Buy |
331
+56
| +20% | +$5.28K | 0.02% | 196 |
|
|
2017
Q3 | $24K | Sell |
275
-350
| -56% | -$26.6K | 0.02% | 212 |
|
|
2017
Q2 | $45K | Buy |
625
+412
| +193% | +$27.7K | 0.03% | 163 |
|
|
2017
Q1 | $14K | Sell |
213
-36
| -14% | -$2.26K | 0.01% | 304 |
|
|
2016
Q4 | $16K | Sell |
249
-143
| -36% | -$8.73K | 0.01% | 291 |
|
|
2016
Q3 | $25K | Sell |
392
-1,432
| -79% | -$92.7K | 0.02% | 200 |
|
|
2016
Q2 | $113K | Buy |
1,824
+1,256
| +221% | +$76.5K | 0.1% | 88 |
|
|
2016
Q1 | $32K | Hold |
568
| – | – | 0.03% | 167 |
|
|
2015
Q4 | $34K | Hold |
568
| – | – | 0.03% | 164 |
|
|
2015
Q3 | $31K | Sell |
568
-245
| -30% | -$15.9K | 0.03% | 175 |
|
|
2015
Q2 | $55K | Buy |
813
+25
| +3% | +$1.63K | 0.04% | 143 |
|
|
2015
Q1 | $46K | Hold |
788
| – | – | 0.04% | 156 |
|
|
2014
Q4 | $52K | Buy |
+788
| New | +$49.7K | 0.04% | 156 |
|
Other funds holding ABBV
Glassman Wealth Services's ABBV Position: Q1 2024 in Review
Glassman Wealth Services sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 4,153 shares — an estimated $644K sold.
Glassman Wealth Services first reported a position in ABBV in Q4 2014 and held it in 37 quarters. The position peaked at $760K in Q1 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Glassman Wealth Services reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 4,153 AbbVie shares in Q1 2024, an estimated $644K.
- Glassman Wealth Services first reported a position in AbbVie in Q4 2014 and held it in 37 quarters.
- Glassman Wealth Services's AbbVie position peaked at $760K in Q1 2023.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.